Research carried out by the Universities of Nottingham, Southampton and Southampton Hospital in collaboration with Zelemiq Ltd showed that the device can continuously monitor respiratory rate at up to two breaths per minute. This type of monitoring allows for timely detection of changes in respiratory activity, which can be the first signs of deterioration in various diseases, including sepsis and COVID-19.
The main advantage of the new product is that it is non-invasive and does not cause discomfort, unlike existing methods such as the use of masks or chest straps. The device, called a pneumorator, uses sensors to measure changes associated with chest expansion, or changes in the composition of the lungs.
This device connects to a smartphone or tablet, allowing the medical team to quickly monitor data and receive early warnings about the patient’s condition.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
